CN110354202A - The preparation process of glutinous rehmannia Xiaoke Tablets - Google Patents
The preparation process of glutinous rehmannia Xiaoke Tablets Download PDFInfo
- Publication number
- CN110354202A CN110354202A CN201910695170.9A CN201910695170A CN110354202A CN 110354202 A CN110354202 A CN 110354202A CN 201910695170 A CN201910695170 A CN 201910695170A CN 110354202 A CN110354202 A CN 110354202A
- Authority
- CN
- China
- Prior art keywords
- glutinous rehmannia
- xiaoke
- tablets
- tablet
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000405414 Rehmannia Species 0.000 title claims abstract description 74
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000000605 extraction Methods 0.000 claims abstract description 38
- 238000001035 drying Methods 0.000 claims abstract description 31
- 239000000284 extract Substances 0.000 claims abstract description 29
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000000945 filler Substances 0.000 claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 15
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 15
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 15
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 15
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 14
- 239000009636 Huang Qi Substances 0.000 claims abstract description 13
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 13
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 12
- 238000010992 reflux Methods 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 239000012141 concentrate Substances 0.000 claims abstract description 7
- 229960000935 dehydrated alcohol Drugs 0.000 claims abstract description 6
- 239000006286 aqueous extract Substances 0.000 claims abstract description 4
- 238000000967 suction filtration Methods 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 239000002245 particle Substances 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 11
- 239000008187 granular material Substances 0.000 claims description 9
- 239000011122 softwood Substances 0.000 claims description 9
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims description 7
- 235000019441 ethanol Nutrition 0.000 claims description 7
- 238000007667 floating Methods 0.000 claims description 7
- 239000000905 isomalt Substances 0.000 claims description 7
- 235000010439 isomalt Nutrition 0.000 claims description 7
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims description 7
- 206010013786 Dry skin Diseases 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- 238000005485 electric heating Methods 0.000 claims description 6
- 229960004756 ethanol Drugs 0.000 claims description 6
- 239000011521 glass Substances 0.000 claims description 6
- 239000004375 Dextrin Substances 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 4
- 235000019425 dextrin Nutrition 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000007689 inspection Methods 0.000 claims description 2
- 238000007605 air drying Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 abstract description 7
- 239000003826 tablet Substances 0.000 description 58
- 238000012360 testing method Methods 0.000 description 14
- 239000000314 lubricant Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 150000004676 glycans Chemical class 0.000 description 9
- 229920001282 polysaccharide Polymers 0.000 description 9
- 239000005017 polysaccharide Substances 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 238000003809 water extraction Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- -1 iridoid glycosides compound Chemical class 0.000 description 5
- 239000000080 wetting agent Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000011812 mixed powder Substances 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 238000007873 sieving Methods 0.000 description 3
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- 238000000540 analysis of variance Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- CUXYLFPMQMFGPL-BGDVVUGTSA-N (9Z,11E,13Z)-octadecatrienoic acid Chemical compound CCCC\C=C/C=C/C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-BGDVVUGTSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- 102000003712 Complement factor B Human genes 0.000 description 1
- 108090000056 Complement factor B Proteins 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- FYGDTMLNYKFZSV-MRCIVHHJSA-N dextrin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](CO)OC(O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-MRCIVHHJSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 150000008145 iridoid glycosides Chemical class 0.000 description 1
- 150000002584 ketoses Chemical class 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- DKXULEFCEORBJK-UHFFFAOYSA-N magnesium;octadecanoic acid Chemical compound [Mg].CCCCCCCCCCCCCCCCCC(O)=O DKXULEFCEORBJK-UHFFFAOYSA-N 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- CUXYLFPMQMFGPL-UYWAGRGNSA-N trichosanic acid Natural products CCCCC=C/C=C/C=CCCCCCCCC(=O)O CUXYLFPMQMFGPL-UYWAGRGNSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses the preparation processes of glutinous rehmannia Xiaoke Tablets, the formula material of glutinous rehmannia Xiaoke Tablets is glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae, CMS-Na, dehydrated alcohol, magnesium stearate, filler, the following steps are included: step 1: being cleaned by ultrasonic cleaner to glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae, powder mixing is broken by pulverizer in prescription ratio, it is put into Soxhlet extractor, add 8-12 times of water, refluxing extraction, it extracts 1-3 times, 2h is extracted every time, obtains aqueous extract；Step 2: obtained extracting solution is filtered with suction filtration machine, is concentrated with Rotary Evaporators, then concentrate is put into electric drying oven with forced convection.Products obtained therefrom of the present invention meets pharmacopeia defined by the hardness determination of tablet, friability detection, tablet weight variation, disintegration time limited detection, and traditional decoction is changed to tablet, and convenient for saving, transporting, patient is easy to receive, and bioavilability is good.
Description
Technical field
The present invention relates to technical field of pharmaceuticals, the specially preparation process of glutinous rehmannia Xiaoke Tablets.
Background technique
Improved with living standard, one of the people with corresponding disease also gradually increases, and diabetes are, diabetes it is main
Symptom is hyperglycemia, and causing factor is due to insulin secretion failure, and sick blood vessel, kidney, heart, eye etc. of will lead to too long is organized
Many damages, damage relevant organ dysfunction.
In the theory of Chinese medicine, diabetes be referred to as " diabetes ", the world medically, China to this disease earliest record
In Huangdi's Internal Classics, mainly stomach and kidney are got angry scorching, consume excessive body fluid, the time can injure long very much it is excessive, so causing
Other internal organs organs it is impaired to corresponding complication occur.
There is history for a long time using glutinous rehmannia treatment diabetes, " book on Chinese herbal medicine is newly organized ", " Synopsis Golden Chamber ", " prescriptions worth thousand gold " etc. are all to use
Glutinous rehmannia preferably treats the effect quenched one's thirst as key medicine, from the arrival of different medicine compatibilities, from ancient times to the present to have application more.
" Diabetes decoction " comes from " prescriptions worth thousand gold " written by SUN Si miao, can relieve inflammation or internal heat, help, has tonifying spleen, nourshing kidney, promotes the production of body fluid, heat-clearing, benefit
The effect of blood, can tonneau three it is burnt, can alleviate that eating for diabete performance is more, urine is more and people is aobvious thin, be easy tired out, sleep quality
The symptoms such as difference.
Glutinous rehmannia nourishing Yin and promoting production of body fluid in side, heat-clearing kidney tonifying；Radix Astragali ascending YANG and invigorating QI, fosters the spirit of nobility and promotes the production of body fluid, and is all monarch drug in a prescription, and radices trichosanthis heat-clearing is rushed down
Fire promotes the production of body fluid to quench thirst；Radix Ophiopogonis clearing heat and promoting fluid, nourishing Yin and moistening lung；Stomach is mended in Chinese yam tonifying spleen, is all ministerial drug, and pueraria lobata rising Yang cloth saliva, is adjutant,
Radix Glycyrrhizae, can reconcile drug effect, be to make medicine, this several medicines have small component to play a major role.
This prescription is used till today, and the development with experience different generations and doctor is perfect, there is a good curative effect, but due to
Its conventional dosage forms decoction, applies and is restricted, and decoction is time-honored a kind of dosage form from ancient times to the present, it is convenient for absorbing, but
Highly volatile, decoction need to take juice to remove slag, process relatively overelaborates, and to the time of decoction, fire by decocting Chinese medicine
It waits, equipment has certain requirement, and should not save.
Summary of the invention
The purpose of the present invention is to provide the preparation process of glutinous rehmannia Xiaoke Tablets, have glutinous rehmannia Xiaoke Tablets be easy to use it is excellent
Point solves glutinous rehmannia and quenches one's thirst decoction inconvenient problem with use.
To achieve the above object, the invention provides the following technical scheme: the preparation process of glutinous rehmannia Xiaoke Tablets, glutinous rehmannia Xiaoke Tablets
Formula material be glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae, CMS-Na, dehydrated alcohol, magnesium stearate, fill out
Fill agent, comprising the following steps:
Step 1: glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae are cleaned by ultrasonic cleaner,
Powder mixing is broken by pulverizer in prescription ratio, is put into Soxhlet extractor, adds 8-12 times of water, refluxing extraction is extracted
1-3 times, 2h is extracted every time, obtains aqueous extract；
Step 2: obtained extracting solution is filtered with suction filtration machine, is concentrated with Rotary Evaporators, concentrate is then put into electric heating
In air dry oven, the temperature of electric drying oven with forced convection is 60 DEG C, dry to constant weight, obtains dry extract；
Step 3: taking dry extract and filler to mix in 1: 1,1: 3,1: 5 ratio, and be added appropriate 75-95%'s
1-5% disintegrating agent CMS-Na is added in dehydrated alcohol, is mixed to prepare softwood, crosses 20 mesh medicines sieve, particle is made, is put into electric heating air blast
60 DEG C of dryings in drying box are taken out, and 0.1-0.5% magnesium stearate is added, and are carried out tabletting using tablet press machine, are obtained glutinous rehmannia and quench one's thirst
Piece；
Step 4: glutinous rehmannia Xiaoke Tablets 20 are taken at random, is first weighed using assay balance, then calculate average slice weight, it is then accurate
The weight for weighing single yellow Xiaoke Tablets, compares single slice weight and average slice weight, detects to the slice weight of glutinous rehmannia Xiaoke Tablets；
Step 5: the hanging basket of instrument being fixed, is put into 1000ml beaker, adjustment hanging basket can be up and down, bottom of the beaker
37 DEG C of temperature of water pours into away from sieve 25mm in portion, allows the water to submergence sieve and the 25mm when highest water surface is higher by sieve highest point,
Take glutinous rehmannia Xiaoke Tablets 12 at random, be respectively put into the glass tube of hanging basket, to carry out check glutinous rehmannia Xiaoke Tablets disintegration time limited into
Row detection；
Step 6: randomly selecting glutinous rehmannia Xiaoke Tablets 20, check tablet with tablet hardness instrument, detect the hard of glutinous rehmannia Xiaoke Tablets
Degree；
Step 7: randomly selecting glutinous rehmannia Xiaoke Tablets 55, the floating powder on surface is blown away with hair dryer, claims its gross mass, is put into piece
In the glass cylinder of agent friability instrument, setting revolving speed is 25r/min, is taken out after 4min, then blow away floating powder on surface with hair dryer, is weighed
Gross weight calculates the weight of loss, detects to the tablet friability of glutinous rehmannia Xiaoke Tablets；
Step 8: taking dry funnel and funnel is fixed on iron stand, spread a blank sheet of paper in the underface of bell mouth, survey
The distance for measuring bell mouth and paper is denoted as H, the particle that granulation obtains slowly is poured into funnel close to hopper walls, until granule
Until the vertebral height formed at bell mouth is equal to height of the bell mouth apart from blank sheet of paper, measure what granule was formed in paper
Centrum diameter is denoted as R, and the base angle ∠ α of granule cone is calculated according to formula tan α=H/R, and ∠ α is angle of repose, disappears to glutinous rehmannia
The angle of repose of thirsty piece is calculated.
Preferably, the filler can be dextrin or lactose or isomalt.
Preferably, the step 4,5,6 and 7 are detected by tablet four with detector.
Glutinous rehmannia: the monarch drug in a prescription in the side of being, effective component are Dihuang polysaccharide, and oligosaccharides, a variety of glycosides include iridoid glycoside
Class, Catalpol, for iridoid glycosides compound and Dihuang polysaccharide, so using reflux water extraction method.
Radix Astragali: monarch drug in a prescription in the side of being, effective component have an astragaloside, polysaccharide, flavone compound, in order to obtain polysaccharide, institute
Using the water extraction method that flows back.
Radices trichosanthis: ministerial drug in the side of being, effective component are saponins, trichosanic acid, polysaccharide etc., in order to obtain polysaccharose substance,
So using reflux water extraction method.
Chinese yam: ministerial drug in the side of being, effective component are saponin(e, Chinese yam polysaccharide etc., in order to obtain Chinese yam polysaccharide, so using back
Day-to-day drawing method.
Radix Ophiopogonis: ministerial drug in the side of being, effective component are saponins compound, polysaccharide, flavones, in order to obtain polysaccharide, so adopting
With reflux water extraction method.
Pueraria lobata: adjutant in the side of being, effective component are daidzin, Puerarin etc., and Puerarin, flows back so using in order to obtain
Water extraction method.
Radix Glycyrrhizae: making medicine in the side of being, effective component is liquiritin, glycyrrhizin etc., and glycyrrhizin, flows back so using in order to obtain
Water extraction method.
Compared with prior art, beneficial effects of the present invention are as follows: products obtained therefrom of the present invention by the hardness determination of tablet,
Friability detection, tablet weight variation, disintegration time limited detection meet pharmacopeia defined, and traditional decoction is changed to tablet, convenient for saving,
Transport, patient is easy to receive, and bioavilability is good.
Detailed description of the invention
Fig. 1 is the curve graph of extraction time of the present invention and paste-forming rate；
Fig. 2 is the curve graph of extraction time and paste-forming rate of the invention；
Fig. 3 is the curve graph of the present invention plus water multiple and paste-forming rate.
Specific embodiment
The technical scheme in the embodiments of the invention will be clearly and completely described below, it is clear that described implementation
Example is only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, this field is common
Technical staff's every other embodiment obtained without making creative work belongs to the model that the present invention protects
It encloses.
Fig. 1-3, the preparation process of glutinous rehmannia Xiaoke Tablets are please referred to, the formula material of glutinous rehmannia Xiaoke Tablets is glutinous rehmannia, Radix Astragali, smallpox
Powder, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae, CMS-Na, dehydrated alcohol, magnesium stearate, filler, comprising the following steps:
Step 1: glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae are cleaned by ultrasonic cleaner,
Powder mixing is broken by pulverizer in prescription ratio, is put into Soxhlet extractor, adds 8-12 times of water, refluxing extraction is extracted
1-3 times, 2h is extracted every time, obtains aqueous extract；
Step 2: obtained extracting solution is filtered with suction filtration machine, is concentrated with Rotary Evaporators, concentrate is then put into electric heating
In air dry oven, the temperature of electric drying oven with forced convection is 60 DEG C, dry to constant weight, obtains dry extract；
Step 3: taking dry extract and filler to mix in 1: 1,1: 3,1: 5 ratio, and be added appropriate 75-95%'s
1-5% disintegrating agent CMS-Na is added in dehydrated alcohol, is mixed to prepare softwood, crosses 20 mesh medicines sieve, particle is made, is put into electric heating air blast
60 DEG C of dryings in drying box are taken out, and 0.1-0.5% magnesium stearate is added, and are carried out tabletting using tablet press machine, are obtained glutinous rehmannia and quench one's thirst
Piece；
Step 4: glutinous rehmannia Xiaoke Tablets 20 are taken at random, is first weighed using assay balance, then calculate average slice weight, it is then accurate
The weight for weighing single yellow Xiaoke Tablets, compares single slice weight and average slice weight, detects to the slice weight of glutinous rehmannia Xiaoke Tablets；
Step 5: the hanging basket of instrument being fixed, is put into 1000ml beaker, adjustment hanging basket can be up and down, bottom of the beaker
37 DEG C of temperature of water pours into away from sieve 25mm in portion, allows the water to submergence sieve and the 25mm when highest water surface is higher by sieve highest point,
Take glutinous rehmannia Xiaoke Tablets 12 at random, be respectively put into the glass tube of hanging basket, to carry out check glutinous rehmannia Xiaoke Tablets disintegration time limited into
Row detection；
Step 6: randomly selecting glutinous rehmannia Xiaoke Tablets 20, check tablet with tablet hardness instrument, detect the hard of glutinous rehmannia Xiaoke Tablets
Degree；
Step 7: randomly selecting glutinous rehmannia Xiaoke Tablets 55, the floating powder on surface is blown away with hair dryer, claims its gross mass, is put into piece
In the glass cylinder of agent friability instrument, setting revolving speed is 25r/min, is taken out after 4min, then blow away floating powder on surface with hair dryer, is weighed
Gross weight calculates the weight of loss, detects to the tablet friability of glutinous rehmannia Xiaoke Tablets；
Step 8: taking dry funnel and funnel is fixed on iron stand, spread a blank sheet of paper in the underface of bell mouth, survey
The distance for measuring bell mouth and paper is denoted as H, the particle that granulation obtains slowly is poured into funnel close to hopper walls, until granule
Until the vertebral height formed at bell mouth is equal to height of the bell mouth apart from blank sheet of paper, measure what granule was formed in paper
Centrum diameter is denoted as R, and the base angle ∠ α of granule cone is calculated according to formula tan α=H/R, and ∠ α is angle of repose, disappears to glutinous rehmannia
The angle of repose of thirsty piece is calculated.
The design of extraction process single factor experiment
In order to select preferably extraction factor, successively to the time of extraction, extraction time, Extracting temperature these three factors
It investigates, using paste-forming rate as index, finally determines optimal extraction factor.
Glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae break into powder mixing in prescription ratio, add 12 times
Water, refluxing extraction extract 2h, extract 1 time respectively, extract 2 times, extract 3 times, are concentrated with Rotary Evaporators, claim the weight of drying basin
Amount, then concentrate is poured out and is put into drying basin, and be put into drying box, and drying box temperature is 60 DEG C, drying to constant weight,
It takes out and weighs, calculate separately to obtain paste-forming rate.
Paste-forming rate=dry cream amount/medicinal material amount * 100%
Glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae break into powder mixing in prescription ratio, add 12 times of water,
Refluxing extraction extracts 60,90,120,150,180min respectively, extracts 2 times, the extracting solution being concentrated to get with Rotary Evaporators, claims
The weight of drying basin, then concentrate is poured out be put into drying basin, is put into drying box, and drying box temperature is 60 DEG C, dry
To constant weight, takes out and weigh, calculate separately to obtain paste-forming rate.
Paste-forming rate=dry cream amount/medicinal material amount * 100%
Glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae in prescription ratio break into powder mixing, respectively plus 8,
10,12,14 times of water, refluxing extraction extract 2h, extract 2 times, the extracting solution being concentrated to get with Rotary Evaporators, claim drying basin
Weight, then concentrate is poured out and is put into drying basin, is put into drying box, drying box temperature is 60 DEG C, dry to constant weight,
It takes out and weighs, calculate separately to obtain paste-forming rate.
Paste-forming rate=dry cream amount/medicinal material amount * 100%
Using reflux extraction, selection and withdrawal number (A), extraction time (B) plus water multiple (C) are three factors, design
Three levels do 3 factor level tables, and inspection target is paste-forming rate, are tested with L9 (34) orthogonal trial.
Extraction process Orthogonal Experiment and Design
Table 2-4 factor level table
| Test serial number | Extraction time (A) | Extraction time (B) | Solid-liquid ratio (C) |
| 1 | 1 | 90 | 1∶10 |
| 2 | 2 | 120 | 1∶12 |
| 3 | 3 | 150 | 1∶14 |
It takes dry extract and isomalt to mix in 1: 1,1: 3,1: 5 ratio, and appropriate wetting agent is added
95% ethyl alcohol is added 3% disintegrating agent CMS-Na, is mixed to prepare softwood, crosses 20 meshes, be made particle be put into drying box 60 DEG C it is dry
It is dry, it takes out, 0.5% magnesium stearate lubricant is added, influence of the different major ingredient dosages to glutinous rehmannia Xiaoke Tablets quality is investigated in tabletting.
Tablet prepares single factor experiment design
It takes dry extract to add the fillers such as dextrin, lactose, isomalt respectively, is mixed with 1: 3 ratio, and
Appropriate 95% ethyl alcohol of wetting agent is added, 3% disintegrating agent CMS-Na is added, is mixed to prepare softwood, crosses 20 meshes, particle is made, puts
Enter 60 DEG C of dryings in drying box, take out, 0.5% magnesium stearate lubricant is added, tabletting investigates different fillers and quenches one's thirst to glutinous rehmannia
The influence of tablet quality.
Dry extract is mixed with filler, medicinal extract and filler ratio are 1: 3, by mixed powder and various concentration
75%, 85%, 95% ethyl alcohol mixing, is added 3% disintegrating agent CMS-Na, makes softwood, and sieving makes particle, is put into drying
60 DEG C of dryings in case are taken out, and 0.5% magnesium stearate lubricant is added, and tabletting investigates various concentration wetting agent to glutinous rehmannia Xiaoke Tablets matter
The influence of amount.
Dry extract is mixed with filler, medicinal extract and filler ratio are 1: 3, by mixed powder respectively with 1%,
2%, 3%, 4%, 5% disintegrating agent CMS-Na mixing, makes softwood, and sieving makes particle, is put into drying box and does for 60 DEG C
It is dry, it takes out, adds 0.5% magnesium stearate lubricant, influence of the different disintegrating agent dosages to glutinous rehmannia Xiaoke Tablets quality is investigated in tabletting.
Dry extract is mixed with filler, medicinal extract and filler ratio are 1: 3, and appropriate profit is added in mixed powder
3% disintegrating agent CMS-Na is added in 95% ethyl alcohol of humectant, makes softwood, and sieving makes particle, is put into 60 DEG C of dryings in drying box,
Take out, respectively plus 0.1%, 0.2%, 0.3%, 4%, 0.5% magnesium stearate lubricant, tabletting investigates different lubricants and uses
Measure the influence to glutinous rehmannia Xiaoke Tablets quality.
Tablet producing technology Orthogonal Experiment and Design
Major ingredient ratio (A), three filler type (B), lubricant quantity (C) factors are chosen, it is excellent according to method of weighting scores
Change the preparation process of glutinous rehmannia Xiaoke Tablets.
Table 2-1 factor level table
| Test serial number | Major ingredient dosage (A) | Filler type (B) | Lubricant quantity (C) |
| 1 | 1∶1 | Dextrin | 3% |
| 2 | 1∶3 | Isomalt | 5% |
| 3 | 1∶5 | Microcrystalline cellulose | 7% |
Extraction process single factor experiment result and analysis
Influence of the table 3-1 extraction time to paste-forming rate
| Extraction time | 1 | 2 | 3 |
| Paste-forming rate % | 28.67 | 31.12 | 31.21 |
Paste-forming rate is affected by extraction time known to table 3-1 data, and paste-forming rate when extracting one time is minimum, extracts two
Paste-forming rate when secondary rises, when extracting three times paste-forming rate be improved but seldom, almost highest availability, therefore optimal mention
Taking number is 2 times.
Influence of the table 3-2 extraction time to paste-forming rate
| Extraction time min | 60 | 90 | 120 | 150 | 180 |
| Paste-forming rate % | 25.40 | 28.81 | 31.39 | 31.48 | 31.45 |
Paste-forming rate is affected by extraction time known to table 3-2, and the time increases paste-forming rate and is also gradually increased, and extracts 1h's
Paste-forming rate is minimum, extracts the paste-forming rate highest of 2.5h, and paste-forming rate starts to stablize after extracting 2h, no longer increases, therefore extracts best
Extraction time is 2h.
Table 3-3 adds influence of the water multiple to paste-forming rate
| Add water multiple | 8 | 10 | 12 | 14 |
| Paste-forming rate | 30.15 | 30.82 | 31.18 | 31.24 |
Can be it is found that with the increase for adding water multiple by surface 3-3, paste-forming rate also gradually rises, when adding water multiple to reach 12
After times, paste-forming rate tends towards stability, therefore 12 times of water is added to be most preferably to add water multiple.
Extraction process orthogonal experiments and analysis
The intuitive analytical table of table 3-4
| Serial number | Extraction time | Extraction time | Add water multiple | Blank | Paste-forming rate |
| Test 1 | 1 | 1 | 1 | 1 | 11.21% |
| Test 2 | 1 | 2 | 2 | 2 | 19.6% |
| Test 3 | 1 | 3 | 3 | 3 | 11.29% |
| Test 4 | 2 | 1 | 2 | 3 | 29.69% |
| Test 5 | 2 | 2 | 3 | 1 | 31.27% |
| Test 6 | 2 | 3 | 1 | 2 | 30.82% |
| Test 7 | 3 | 1 | 3 | 2 | 30.54% |
| Test 8 | 3 | 2 | 1 | 3 | 31.12% |
| Test 9 | 3 | 3 | 2 | 1 | 30.34% |
| K1 | 14.060 | 23.813 | 24.383 | 24.273 | |
| K2 | 30.553 | 27.357 | 26.570 | 27.013 | |
| K3 | 30.567 | 24.150 | 24.367 | 24.033 | |
| R | 16.607 | 3.544 | 2.203 | 2.980 |
Table 3-5 analysis of variance table
| Processing | Sum of square of deviations | Freedom degree | It is square | F value | Conspicuousness |
| Number (A) | 549.138 | 2 | 274.569 | 33.391 | * |
| Time (B) | 22.951 | 2 | 11.476 | 1.396 | |
| Solid-liquid ratio (C) | 9.636 | 2 | 4.818 | 0.886 | |
| Error | 6.446 | 2 | 1.297 |
Infuse F(0.05)=19.0 F(0.01)=99.0
From variance analysis as can be seen that the extraction factor for influencing paste-forming rate size is followed successively by A > B > C, wherein factor A is mentioned
Take times influence very significant, factor B extraction time influence it is smaller, factor C add water multiple influence not significant, A3B2C2Extraction process
It is more excellent, but variable quantity is seldom, it is contemplated that and time and cost finally determine that optimal extraction process is A2B2C2That is extraction time 2
Secondary, extraction time 90min, 12 times of amount of water are optimum extraction process.
Tablet producing technology single factor experiment result and analysis
The selection of table 3-6 major ingredient dosage and result
| Proportion of main and supplementary materials | Disintegration time limited (min) | Mouthfeel | Appearance | Weighted scoring |
| 1∶1 | 12.2 | 6.8 | 5.4 | 5.4 |
| 1∶3 | 13.5 | 8.6 | 7.9 | 8.3 |
| 1∶5 | 13.8 | 8.1 | 8.2 | 8.1 |
1: 1 and 1: 3 is all proper ratio known to table 3-6, and tabletting flat appearance is smooth, it is contemplated that this product mouthfeel, so
Select proportion of main and supplementary materials 1: 3 for optimal proportion.
The selection of table 3-7 filler type and result
| Filler type | Disintegration time limited | Mouthfeel | Appearance | Weighted scoring |
| Dextrin | 12.6 | 2.9 | 8.1 | 3.2 |
| Microcrystalline cellulose | 12.1 | 3.1 | 8.0 | 3.5 |
| Isomalt | 13.3 | 8.8 | 8.2 | 8.6 |
By table 3-7 it is found that three kinds of filler mouldabilities are not much different, it is contemplated that experimental design background, so selecting different wheat
Bud ketose alcohol is best packing material.
The selection of table 3-8 wetting agent and result
| Concentration of wetting agent % | Disintegration time limited min | Ratio of briquetting % | Weight score |
| 75 | 15.37 | 78% | 7.5 |
| 85 | 15.63 | 83% | 8.2 |
| 95 | 15.88 | 91% | 8.7 |
By table 3-9 it is found that being most suitable for granulation using the softwood that the ethyl alcohol of 95% concentration is made.
The influence result of table 3-9 disintegrating agent dosage
| Disintegrating agent dosage % | Disintegration time limited min | Ratio of briquetting % | Weight score |
| 1 | 17.7 | 74 | 7.1 |
| 2 | 15.4 | 78 | 7.5 |
| 3 | 13.6 | 89 | 8.1 |
| 4 | 11.2 | 87 | 7.9 |
| 5 | 9.9 | 77 | 7.3 |
By table 3-9 it is found that with disintegrating agent dosage raising, disintegration time is declined, but the excessively high meeting of disintegrating agent dosage
Tablet compactibility energy is influenced, so selecting 3% sodium carboxymethyl starch for optimal proportion.
Tablet producing technology orthogonal experiments and analysis
The intuitive analytical table of table 3-10
Table 3-11 analysis of variance table
| Factor | Sum of square of deviations | Freedom degree | It is square | F value | Conspicuousness |
| A | 2.645 | 2 | 1.323 | 44.117 | * |
| B | 1.647 | 2 | 0.824 | 27.450 | * |
| C | 1.807 | 2 | 0.904 | 30.117 | * |
| D | 0.060 | 2 | 0.030 | 1.000 | |
| Error | 0.06 | 2 | 0.03 |
Three factors all have a significant impact the preparation process of glutinous rehmannia Xiaoke Tablets it can be seen from table 3-11, influence power
Size is followed successively by A > C > B, wherein A2B2C3Score highest, that is, uses 1: 3 main and supplementary materials ratio, filled using isomalt
Agent is added 0.5% magnesium stearate and does lubricant, is that optimal glutinous rehmannia is quenched one's thirst piece preparation method.
The quality examination result of glutinous rehmannia Xiaoke Tablets
Table 3-12 organoleptic detection result table
Learn that glutinous rehmannia Xiaoke Tablets appearance is glossy by table 3-10, without slight crack, uniform color is complied with standard.
Table 3-13 weight differential result table
| Serial number | Serial number | ||
| 1 | 0.121 | 11 | 0.122 |
| 2 | 0.117 | 12 | 0.115 |
| 3 | 0.124 | 13 | 0.119 |
| 4 | 0.129 | 14 | 0.121 |
| 5 | 0.121 | 15 | 0.117 |
| 6 | 0.125 | 16 | 0.124 |
| 7 | 0.131 | 17 | 0.126 |
| 8 | 0.118 | 18 | 0.118 |
| 9 | 0.119 | 19 | 0.127 |
| 10 | 0.124 | 20 | 0.114 |
Table 3-14 limit test of weight variation table
| Slice weight | Limit test of weight variation |
| 0.12g | ± 7.5% |
Average slice weight=0.12g
It is compared by table 3-11 and 3-12 it is found that meeting the weight differential standard of " pharmacopeia " defined.
Table 3-15 disintegration time limited result table
| Serial number | 1 group | 2 groups |
| 1 | 13.5 | 12.8 |
| 2 | 11.2 | 12.3 |
| 3 | 13.6 | 13.8 |
| 4 | 12.4 | 14.2 |
| 5 | 12.8 | 14.4 |
| 6 | 13.6 | 13.4 |
| Average (min) | 12.85 | 13.48 |
By disintegration time limited known to table 3-13 all in 15min, and disintegration time meets pharmacopeia specification greater than 10min.
Table 3-16 Determination of Hardness table
Hardness is in 4-6kg/cm2 known to table 3-14, and by consulting related data, the hardness of general plain piece is in 2-6kg/
Cm2, hardness is preferable, meets regulation.
55 are extracted from glutinous rehmannia Xiaoke Tablets obtained at random, the quality for blowing away floating powder is 6.187g, is placed in tablet friability
The quality of tablet is 6.136g after instrument, and the quality for calculating loss is 0.9%, meets States Pharmacopoeia specifications about the rule of tablet friability
It is fixed, it meets the requirements.
The angle of repose table 3-17 testing result table
| Serial number | Stearic acid magnesium amount (%) | Angle of repose (°) | Weight score |
| 1 | 0.1 | 33.26 | 7.1 |
| 2 | 0.3 | 32.54 | 7.5 |
| 3 | 0.5 | 30.88 | 8.2 |
| 4 | 0.7 | 30.46 | 8.0 |
| 5 | 0.9 | 30.23 | 7.3 |
By table 3-3 it is found that the dosage with lubricant increases, the degree at angle of repose is smaller and smaller, so particle in lozenge
Mobility it is better, but with magnesium stearate content increase lozenge taste bad, so select be added 0.5% it is hard
Fatty acid magnesium is optimal proportion.
It is 0.12 gram that calculating, which learns that glutinous rehmannia Xiaoke Tablets are averaged in piece, and proportion of main and supplementary materials 1: 3 can be calculated according to ratio and know
Average every glutinous rehmannia Xiaoke Tablets formula extraction dry extract containing group: 0.12g*1/4=0.03g.
It although an embodiment of the present invention has been shown and described, for the ordinary skill in the art, can be with
A variety of variations, modification, replacement can be carried out to these embodiments without departing from the principles and spirit of the present invention by understanding
And modification, the scope of the present invention is defined by the appended.
Claims (3)
1. the preparation process of glutinous rehmannia Xiaoke Tablets, the formula material of glutinous rehmannia Xiaoke Tablets be glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis,
Pueraria lobata, Radix Glycyrrhizae, CMS-Na, dehydrated alcohol, magnesium stearate, filler, it is characterised in that: the following steps are included:
Step 1: glutinous rehmannia, Radix Astragali, radices trichosanthis, Chinese yam, Radix Ophiopogonis, pueraria lobata, Radix Glycyrrhizae being cleaned by ultrasonic cleaner, by group
Square ratio breaks into powder mixing by pulverizer, is put into Soxhlet extractor, adds 8-12 times of water, and refluxing extraction extracts 1-3
It is secondary, 2h is extracted every time, obtains aqueous extract；
Step 2: obtained extracting solution is filtered with suction filtration machine, is concentrated with Rotary Evaporators, concentrate is then put into electric heating air blast
In drying box, the temperature of electric drying oven with forced convection is 60 DEG C, dry to constant weight, obtains dry extract；
Step 3: taking dry extract and filler to mix in the ratio of 1:1,1:3,1:5, and the anhydrous of appropriate 75-95% is added
1-5% disintegrating agent CMS-Na is added in ethyl alcohol, is mixed to prepare softwood, crosses 20 mesh medicines sieve, particle is made, is put into electric heating forced air drying
60 DEG C of dryings in case are taken out, and 0.1-0.5% magnesium stearate is added, and are carried out tabletting using tablet press machine, are obtained glutinous rehmannia Xiaoke Tablets；
Step 4: taking glutinous rehmannia Xiaoke Tablets 20 at random, first weighed using assay balance, then calculate average slice weight, then precision weighing
The weight of single Huang Xiaoke Tablets, compares single slice weight and average slice weight, detects to the slice weight of glutinous rehmannia Xiaoke Tablets；
Step 5: the hanging basket of instrument is fixed, is put into 1000ml beaker, adjustment hanging basket can be up and down, beaker bottom away from
Sieve 25mm pours into 37 DEG C of temperature of water, allows the water to submergence sieve and the 25mm when highest water surface is higher by sieve highest point, at random
Glutinous rehmannia Xiaoke Tablets 12 are taken, is respectively put into the glass tube of hanging basket, is examined to inspection glutinous rehmannia Xiaoke Tablets disintegration time limited is carried out
It surveys；
Step 6: randomly selecting glutinous rehmannia Xiaoke Tablets 20, check tablet with tablet hardness instrument, detect the hardness of glutinous rehmannia Xiaoke Tablets；
Step 7: randomly selecting glutinous rehmannia Xiaoke Tablets 55, the floating powder on surface is blown away with hair dryer, claims its gross mass, it is crisp to be put into tablet
In the glass cylinder of broken instrument, setting revolving speed is 25r/min, is taken out after 4min, then blow away floating powder on surface with hair dryer, is weighed total
Weight, calculates the weight of loss, detects to the tablet friability of glutinous rehmannia Xiaoke Tablets；
Step 8: taking dry funnel and funnel is fixed on iron stand, spread a blank sheet of paper in the underface of bell mouth, measure
The distance of bell mouth and paper is denoted as H, the particle that granulation obtains slowly is poured into funnel close to hopper walls, until granule is leaking
Until the vertebral height formed at quarrel is equal to height of the bell mouth apart from blank sheet of paper, the centrum that granule is formed in paper is measured
Diameter is denoted as R, the base angle ∠ α of granule cone is calculated according to formula tan α=H/R, ∠ α is angle of repose, to glutinous rehmannia Xiaoke Tablets
Angle of repose calculated.
2. the preparation process of glutinous rehmannia Xiaoke Tablets according to claim 1, it is characterised in that: the filler can be dextrin
Or lactose or isomalt.
3. the preparation process of glutinous rehmannia Xiaoke Tablets according to claim 1, it is characterised in that: the step 4,5,6 and 7 are logical
Tablet four is crossed to be detected with detector.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910695170.9A CN110354202A (en) | 2019-07-30 | 2019-07-30 | The preparation process of glutinous rehmannia Xiaoke Tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910695170.9A CN110354202A (en) | 2019-07-30 | 2019-07-30 | The preparation process of glutinous rehmannia Xiaoke Tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110354202A true CN110354202A (en) | 2019-10-22 |
Family
ID=68222698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910695170.9A Pending CN110354202A (en) | 2019-07-30 | 2019-07-30 | The preparation process of glutinous rehmannia Xiaoke Tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110354202A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113041316A (en) * | 2021-03-20 | 2021-06-29 | 洛阳蓝凯生物科技有限公司 | Natural herbal tea capable of reducing blood sugar and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1679869A (en) * | 2004-03-17 | 2005-10-12 | 北京奇源益德药物研究所 | Preparation for diabetes and its making method |
| CN103191295A (en) * | 2013-04-18 | 2013-07-10 | 高伟 | Medicine for treating diabetes mellitus |
-
2019
- 2019-07-30 CN CN201910695170.9A patent/CN110354202A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1679869A (en) * | 2004-03-17 | 2005-10-12 | 北京奇源益德药物研究所 | Preparation for diabetes and its making method |
| CN103191295A (en) * | 2013-04-18 | 2013-07-10 | 高伟 | Medicine for treating diabetes mellitus |
Non-Patent Citations (1)
| Title |
|---|
| 刘宝华等: "针刺配合中药治疗Ⅱ型糖尿病30例", 《针灸临床杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113041316A (en) * | 2021-03-20 | 2021-06-29 | 洛阳蓝凯生物科技有限公司 | Natural herbal tea capable of reducing blood sugar and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104784505B (en) | A kind of Dendrobium officinale health product of auxiliary hyperglycemic and preparation method thereof | |
| CN102178874B (en) | Preparation method of Chinese medicinal tablet for treating skin diseases | |
| CN111195314A (en) | Traditional Chinese medicine composition for nourishing stomach and promoting digestion and preparation method thereof | |
| CN104352884B (en) | A kind of Chinese medicine composition for being used to treat stationary phase chronic obstructive pulmonary disease | |
| CN102526427B (en) | Traditional Chinese medicinal composition for treating gastrointestinal diseases and quality inspection method | |
| CN110354202A (en) | The preparation process of glutinous rehmannia Xiaoke Tablets | |
| CN101049440B (en) | Preparation of Chinese traditional medicine in use for diabetes, and preparation method | |
| CN102078543A (en) | Traditional Chinese medicine preparation for treating gout and preparation method thereof | |
| CN106177432A (en) | A kind of health composition comprising leaf of Cyclocarya paliurus Iljinskaja, Folium Mori, green tea and Rhizoma Polygonati Odorati | |
| CN115531463B (en) | Traditional Chinese medicine for treating hyperlipidemia | |
| CN105394765B (en) | A kind of composition and preparation method thereof with antiobesity action | |
| CN109157584B (en) | Composition with auxiliary blood fat reducing function and preparation method and application thereof | |
| CN105770052A (en) | Preparation method of semen ziziphi spinosae dispersible tablets and semen ziziphi spinosae dispersible tablets | |
| CN105535391A (en) | Medicine composition for treating pneumonia | |
| CN103285022B (en) | For preparing the Chinese medicine monomer composition and method of making the same for the treatment of polycystic ovarian syndrome | |
| CN100562323C (en) | A kind of pharmaceutical composition for the treatment of hysteromyoma and preparation method thereof | |
| CN105327115B (en) | A kind of prevention and treatment type II diabetes Phellinus is logical to rush down formula and preparation process | |
| CN104042675A (en) | Compound agaricus blazei murill polysaccharide composition and application thereof | |
| CN105641672A (en) | Composition for treating obesity caused by energy metabolism imbalance and preparation | |
| CN104352534B (en) | A kind of fuling peel total triterpene dispersible tablet and preparation method thereof | |
| CN101116686A (en) | Medicine for treating fatness and its complication | |
| CN100457169C (en) | Medicine for treating chronic colitis and its preparing process | |
| WO2022057498A1 (en) | Composition with function of relieving physical fatigue and preparation method therefor | |
| CN103285193B (en) | Lung-tonifying capsule for treating lung-distension caused by qi deficiency of lung and kidney and preparation method thereof | |
| CN102813715A (en) | Compound medicine for treating post-infectious cough and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20191022 |